Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

Government Panel to Review Pharma Marketing Code and Its Enforcement

24 October 2026 · By · Wire by Fusion42

Published

24 October 2026

Topic

regulatory

◆ Sectors

Health

◆ Geography

India

◆ Source

Read at policyedge.in →

◆ Verified

Fusion42 · 24 October 2026 · Fusion42 review

The Indian government has formed a committee to review the enforcement and effectiveness of the Uniform Code for Pharmaceutical Marketing Practices 2024, with authority to recommend stronger regulatory or statutory measures to ensure compliance and transparency in pharmaceutical marketing.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You should prepare for tighter pharma marketing rules and enforcement in India as the government reviews and may strengthen the current code. This panel's recommendations could open new compliance demands that directly affect your marketing and disclosures.

◆ Coverage

1 source · 24 Oct 2026

◆ Related on Wire

◆ Topics

Healthpharma-regulationmarketing-codecompliancehealth-policyindia